Literature DB >> 16437387

Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer.

K Shimada1, M Nakamura, E Ishida, N Konishi.   

Abstract

Mitogen activated protein (MAP) kinases are well known serine threonine kinases that modulate gene expression, mitosis, cell proliferation and programmed cell death or 'apoptosis' in response to various stresses. Extracellular stress regulated kinase (ERK), c-jun NH2 terminal kinase and p38 are major members of the MAP kinases, and there is now a body of evidence of their involvement in genesis or sensitivity to chemotherapy of human prostate cancers. In this review, we focus on the molecular roles of MAP kinases and their pathological correlations, with particular attention to novel downstream signals through phosphorylation of the Fas-associated death domain protein that effectively regulates not only apoptosis but also the cell cycle in prostate neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16437387     DOI: 10.14670/HH-21.415

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  12 in total

1.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

2.  Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.

Authors:  Uma R Chandran; Changqing Ma; Rajiv Dhir; Michelle Bisceglia; Maureen Lyons-Weiler; Wenjing Liang; George Michalopoulos; Michael Becich; Federico A Monzon
Journal:  BMC Cancer       Date:  2007-04-12       Impact factor: 4.430

3.  Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC).

Authors:  James A Eddy; Leroy Hood; Nathan D Price; Donald Geman
Journal:  PLoS Comput Biol       Date:  2010-05-27       Impact factor: 4.475

Review 4.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.

Authors:  Keiji Shimada; Mitsutoshi Nakamura; Eiwa Ishida; Tomonori Higuchi; Motoyoshi Tanaka; Ichiro Ota; Noboru Konishi
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

6.  MAP Kinases and Prostate Cancer.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  J Signal Transduct       Date:  2011-10-20

7.  Cytokine effects on cell viability and death of prostate carcinoma cells.

Authors:  Georgios Chondrogiannis; Michalis Kastamoulas; Panagiotis Kanavaros; Georgios Vartholomatos; Maria Bai; Dimitrios Baltogiannis; Nikolaos Sofikitis; Dimitrios Arvanitis; Vasiliki Galani
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

8.  Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells.

Authors:  Songjiang Wu; Yanying Yang; Feiping Li; Lifu Huang; Zihua Han; Guanfu Wang; Hongyuan Yu; Haiping Li
Journal:  Onco Targets Ther       Date:  2018-05-08       Impact factor: 4.147

9.  Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma.

Authors:  Mikiko Takikita; Nan Hu; Jian-Zhong Shou; Quan-Hong Wang; Carol Giffen; Philip R Taylor; Stephen M Hewitt
Journal:  BMC Cancer       Date:  2009-09-03       Impact factor: 4.430

10.  FADD Phosphorylation Modulates Blood Glucose Levels by Decreasing the Expression of Insulin-Degrading Enzyme.

Authors:  Yan Lin; Jia Liu; Jia Chen; Chun Yao; Yunwen Yang; Jie Wang; Hongqin Zhuang; Zi-Chun Hua
Journal:  Mol Cells       Date:  2020-04-30       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.